COVID-19, Influenza
Conditions
Interventions
None listed
Sponsors
Yamanashi Prefectural Central Hospital
Aillis, Inc., University of Yamanashi Hospital
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: (1) Patients with written consent to participate in the study provided by themselves or their representatives. (2) Patients aged three years or older. (3) Patients with influenza-like symptoms within 48 hours after onset. (4) Patients whose nasopharyngeal swabs were collected for RT-PCR testing of influenza within six hours prior to imaging, or patients whose nasopharyngeal swabs are scheduled to be collected for RT-PCR testing of influenza within six hours after the imaging. (5) Patients whose nasopharyngeal swabs were collected for RT-PCR testing of SARS-CoV-2 within six hours before imaging, or patients whose nasopharyngeal swabs are scheduled to be collected for RT-PCR testing of SARS-CoV-2 within six hours after the imaging.
Exclusion criteria
Exclusion criteria: (1) Patients with fluctuating teeth. (2) Patients with moderate or severe dental diseases. (3) Patients who underwent oropharyngeal procedure such as oropharyngeal swab collection within six hours. (4) Patients who have been vomiting repeatedly. (5) Patients judged to be inappropriate to participate in the study by the physician.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The sensitivity and specificity of Influenza AI compared to RT-PCR analysis for influenza. | — |
Countries
Japan
Contacts
Public ContactTakahiro Mikawa
Yamanashi Prefectural Central Hospital Department of General Internal Medicine and Infectious Diseases
Outcome results
None listed